Clinical Trial Update: Study of ZG006 in Participants With Neuroendocrine Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ZG006 for neuroendocrine prostate cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Prostate Cancer

Drugs mentioned

• ZG006

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Neuroendocrine Prostate Cancer | Phase 2 | Status: NOT_YET_RECRUITING